Evidence map›Paper›PMID 38598055›Full record

ArticleWorld journal of urology2024

Development and validation of a clinical and ultrasound features-based nomogram for preoperative differentiation of renal urothelial carcinoma and central renal cell carcinoma.

Cuixian Li, Beilei Lu, Qing Zhao, Qing Lu, Jingjing Wang, Pei Sun, Huixiong Xu, Beijian Huang

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of urology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Cuixian Li *Department of Ultrasound, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Beilei Lu *Department of Ultrasound, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Qing Zhao *Department of Interventional Radiology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
Qing LuDepartment of Ultrasound, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Jingjing WangDepartment of Ultrasound, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Pei SunDepartment of Ultrasound, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Huixiong XuDepartment of Ultrasound, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Beijian HuangDepartment of Ultrasound, Zhongshan Hospital, Fudan University, Shanghai, 200032, China. huang.beijian@zs-hospital.sh.cn.

Funding

Natural Science Foundation (CN) 12174074Shanghai Municipal Health Commission 202240153Shanghai Municipal Health Commission R2021-007
6 · The paper itself

Abstract

purposeThis study aimed to develop and validate an ultrasound (US)-based nomogram for the preoperative differentiation of renal urothelial carcinoma (rUC) from central renal cell carcinoma (c-RCC).

methodsClinical data and US images of 655 patients with 655 histologically confirmed malignant renal tumors (521 c-RCCs and 134 rUCs) were collected and divided into training (n = 455) and validation (n = 200) cohorts according to examination dates. Conventional US and contrast-enhanced US (CEUS) tumor features were analyzed to determine those that could discriminate rUC from c-RCC. Least absolute shrinkage and selection operator regression was applied to screen clinical and US features for the differentiation of rUC from c-RCC. Using multivariate logistic regression analysis, a diagnostic model of rUC was constructed and visualized as a nomogram. The diagnostic model's performance was assessed in the training and validation cohorts by calculating the area under the receiver operating characteristic curve (AUC) and calibration plot. Decision curve analysis (DCA) was used to assess the clinical usefulness of the US-based nomogram.

resultsSeven features of both clinical features and ultrasound imaging were selected to build the diagnostic model. The nomogram achieved favorable discrimination in the training (AUC = 0.996, 95% CI: 0.993-0.999) and validation (AUC = 0.995, 95% CI: 0.974, 1.000) cohorts, and good calibration (Brier scores: 0.019 and 0.016, respectively). DCA demonstrated the clinical usefulness of the US-based nomogram.

conclusionA noninvasive clinical and US-based nomogram combining conventional US and CEUS features possesses good predictive value for differentiating rUC from c-RCC.

Indexed as

Carcinoma, Renal CellCarcinoma, Transitional CellKidney NeoplasmsUrinary Bladder NeoplasmsHumansNomogramsUltrasonographyDiagnosisNomogramRenal cell carcinomaUltrasonographyUrothelial carcinoma

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.